377 related articles for article (PubMed ID: 25324143)
1. miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer.
Gururajan M; Josson S; Chu GC; Lu CL; Lu YT; Haga CL; Zhau HE; Liu C; Lichterman J; Duan P; Posadas EM; Chung LW
Clin Cancer Res; 2014 Dec; 20(24):6559-69. PubMed ID: 25324143
[TBL] [Abstract][Full Text] [Related]
2. miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer.
Josson S; Gururajan M; Hu P; Shao C; Chu GY; Zhau HE; Liu C; Lao K; Lu CL; Lu YT; Lichterman J; Nandana S; Li Q; Rogatko A; Berel D; Posadas EM; Fazli L; Sareen D; Chung LW
Clin Cancer Res; 2014 Sep; 20(17):4636-46. PubMed ID: 24963047
[TBL] [Abstract][Full Text] [Related]
3. Curcumin Suppresses In Vitro Proliferation and Invasion of Human Prostate Cancer Stem Cells by Modulating DLK1-DIO3 Imprinted Gene Cluster MicroRNAs.
Zhang H; Zheng J; Shen H; Huang Y; Liu T; Xi H; Chen C
Genet Test Mol Biomarkers; 2018 Jan; 22(1):43-50. PubMed ID: 29172709
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
[TBL] [Abstract][Full Text] [Related]
5. Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis.
Josson S; Gururajan M; Sung SY; Hu P; Shao C; Zhau HE; Liu C; Lichterman J; Duan P; Li Q; Rogatko A; Posadas EM; Haga CL; Chung LW
Oncogene; 2015 May; 34(21):2690-9. PubMed ID: 25065597
[TBL] [Abstract][Full Text] [Related]
6. The other face of miR-17-92a cluster, exhibiting tumor suppressor effects in prostate cancer.
Ottman R; Levy J; Grizzle WE; Chakrabarti R
Oncotarget; 2016 Nov; 7(45):73739-73753. PubMed ID: 27650539
[TBL] [Abstract][Full Text] [Related]
7. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
[TBL] [Abstract][Full Text] [Related]
9. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling.
Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D
Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537
[No Abstract] [Full Text] [Related]
10. DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival.
Luk JM; Burchard J; Zhang C; Liu AM; Wong KF; Shek FH; Lee NP; Fan ST; Poon RT; Ivanovska I; Philippar U; Cleary MA; Buser CA; Shaw PM; Lee CN; Tenen DG; Dai H; Mao M
J Biol Chem; 2011 Sep; 286(35):30706-30713. PubMed ID: 21737452
[TBL] [Abstract][Full Text] [Related]
11. A subset of microRNAs in the Dlk1-Dio3 cluster regulates age-associated muscle atrophy by targeting Atrogin-1.
Shin YJ; Kwon ES; Lee SM; Kim SK; Min KW; Lim JY; Lee B; Kang JS; Kwak JY; Son YH; Choi JY; Yang YR; Kim S; Kim YS; Jang HC; Suh Y; Yoon JH; Lee KP; Kwon KS
J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1336-1350. PubMed ID: 32495509
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in the imprinted DLK1-DIO3 region repress the epithelial-to-mesenchymal transition by targeting the TWIST1 protein signaling network.
Haga CL; Phinney DG
J Biol Chem; 2012 Dec; 287(51):42695-707. PubMed ID: 23105110
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Maturation during Muscle Stem Cell Differentiation Is Achieved by miR-1/133a-Mediated Inhibition of the Dlk1-Dio3 Mega Gene Cluster.
Wüst S; Dröse S; Heidler J; Wittig I; Klockner I; Franko A; Bonke E; Günther S; Gärtner U; Boettger T; Braun T
Cell Metab; 2018 May; 27(5):1026-1039.e6. PubMed ID: 29606596
[TBL] [Abstract][Full Text] [Related]
14. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
[TBL] [Abstract][Full Text] [Related]
15. microRNAs and Prostate Cancer.
Josson S; Chung LW; Gururajan M
Adv Exp Med Biol; 2015; 889():105-18. PubMed ID: 26658999
[TBL] [Abstract][Full Text] [Related]
16. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.
Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S
Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363
[TBL] [Abstract][Full Text] [Related]
17. Role of microRNA-141-3p in the progression and metastasis of hepatocellular carcinoma cell.
Hou X; Yang L; Jiang X; Liu Z; Li X; Xie S; Li G; Liu J
Int J Biol Macromol; 2019 May; 128():331-339. PubMed ID: 30695725
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
[TBL] [Abstract][Full Text] [Related]
19. Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT.
Peng X; Guo W; Liu T; Wang X; Tu X; Xiong D; Chen S; Lai Y; Du H; Chen G; Liu G; Tang Y; Huang S; Zou X
PLoS One; 2011; 6(5):e20341. PubMed ID: 21647377
[TBL] [Abstract][Full Text] [Related]
20. MiR-181a promotes epithelial to mesenchymal transition of prostate cancer cells by targeting TGIF2.
Zhiping C; Shijun T; Linhui W; Yapei W; Lianxi Q; Qiang D
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4835-4843. PubMed ID: 29164579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
